Neuroprotection by estrogen and progesterone in traumatic brain injury and spinal cord injury

Current Neuropharmacology

Volumn 14, Issue 6, 2016, Pages 641-653

  Brotfain, Evgeni ^a   Gruenbaum, Shaun E ^b   Boyko, Matthew ^a   Kutz, Ruslan ^a   Zlotnik, Alexander ^a   Klein, Moti ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Estrogen; Neuroprotection; Progesterone; Spinal cord injury; Traumatic brain injury

Indexed keywords

AQUAPORIN 4; CALCIUM CHANNEL L TYPE; CONJUGATED ESTROGEN; ESTROGEN; ESTROGEN RECEPTOR; ETHINYLESTRADIOL; GLUTAMATE RECEPTOR; GLUTAMATE TRANSPORTER; GLUTAMIC ACID; HYDROCORTISONE; NICOTINAMIDE; PREGNENOLONE; PROGESTERONE; NEUROPROTECTIVE AGENT;

ALLERGIC ENCEPHALITIS; ANTIOXIDANT ACTIVITY; ARTICLE; ASTROCYTE; BLOOD BRAIN BARRIER; BRAIN BLOOD FLOW; BRAIN EDEMA; BRAIN METABOLISM; BRAIN REGION; CEREBROSPINAL FLUID LEVEL; DISEASE MODEL; EXTRACELLULAR FLUID; GENDER; GLYCOLYSIS; HIPPOCAMPUS; HUMAN; HYPOTHALAMUS; INFLAMMATION; MICROGLIA; MOTOR PERFORMANCE; MOUSE MODEL; NEOCORTEX; NEUROPROTECTION; NONHUMAN; RAT MODEL; SPINAL CORD INJURY; TRAUMATIC BRAIN INJURY; ANIMAL; BRAIN INJURIES, TRAUMATIC; DRUG EFFECTS; METABOLISM; PHYSIOLOGY; SPINAL CORD INJURIES;

ANIMALS; BRAIN INJURIES, TRAUMATIC; ESTROGENS; HUMANS; NEUROPROTECTION; NEUROPROTECTIVE AGENTS; PROGESTERONE; SPINAL CORD INJURIES;

EID: 84978204154     PISSN: 1570159X     EISSN: 18756190     Source Type: Journal    
DOI: 10.2174/1570159X14666160309123554     Document Type: Article

References (101)

1. Bazarian, J. J.; Blyth, B.; Mookerjee, S.; He, H.; McDermott, M. P. Sex differences in outcome after mild traumatic brain injury. J. Neurotrauma, 2010, 27(3), 527-539. [http://dx. doi. org/10. 1089/neu. 2009. 1068] [PMID: 19938945].
2. Wise, P. M.; Smith, M. J.; Dubal, D. B.; Wilson, M. E.; Rau, S. W.; Cashion, A. B.; Bottner, M.; Rosewell, K. L. Neuroendocrine modulation and repercussions of female reproductive aging. Recent Prog. Horm. Res., 2002, 57, 235-256. [http://dx. doi. org/10. 1210/rp. 57. 1. 235] [PMID: 12017546].
3. Beyer, C. Estrogen and the developing mammalian brain., 1999. [http://dx. doi. org/10. 1007/s004290050236].
4. Johann, S.; Beyer, C. Neuroprotection by gonadal steroid hormones in acute brain damage requires cooperation with astroglia and microglia. J. Steroid Biochem. Mol. Biol., 2013, 137, 71-81. [http://dx. doi. org/10. 1016/j. jsbmb. 2012. 11. 006] [PMID: 23196064].
5. Behl, C. Oestrogen as a neuroprotective hormone. Nat. Rev. Neurosci., 2002, 3(6), 433-442. [PMID: 12042878].
6. Neese, S. L.; Clough, R. W.; Banz, W. J.; Smith, D. C. ZBisdehydrodoisynolic acid (Z-BDDA): an estrogenic seco-steroid that enhances behavioral recovery following moderate fluid percussion brain injury in male rats. Brain Res., 2010, 1362, 93-101. [http://dx. doi. org/10. 1016/j. brainres. 2010. 09. 055] [PMID: 20869954].
7. Roof, R. L.; Hall, E. D. Gender differences in acute CNS trauma and stroke: neuroprotective effects of estrogen and progesterone. J. Neurotrauma, 2000, 17(5), 367-388. [http://dx. doi. org/10. 1089/neu. 2000. 17. 367] [PMID: 10833057].
8. Meltser, I.; Tahera, Y.; Simpson, E.; Hultcrantz, M.; Charitidi, K.; Gustafsson, J. A.; Canlon, B. Estrogen receptor beta protects against acoustic trauma in mice. J. Clin. Invest., 2008, 118(4), 1563-1570. [http://dx. doi. org/10. 1172/JCI32796] [PMID: 18317592].
9. Emerson, C. S.; Headrick, J. P.; Vink, R. Estrogen improves biochemical and neurologic outcome following traumatic brain injury in male rats, but not in females. Brain Res., 1993, 608(1), 95-100. [http://dx. doi. org/10. 1016/0006-8993(93)90778-L] [PMID: 8495351].
10. Zlotnik, A.; Leibowitz, A.; Gurevich, B.; Ohayon, S.; Boyko, M.; Klein, M.; Knyazer, B.; Shapira, Y.; Teichberg, V. I. Effect of estrogens on blood glutamate levels in relation to neurological outcome after TBI in male rats. Intensive Care Med., 2012, 38(1), 137-144. [http://dx. doi. org/10. 1007/s00134-011-2401-3] [PMID: 22124768].
11. Soustiel, J. F.; Palzur, E.; Nevo, O.; Thaler, I.; Vlodavsky, E. Neuroprotective anti-apoptosis effect of estrogens in traumatic brain injury. J. Neurotrauma, 2005, 22(3), 345-352. [http://dx. doi. org/10. 1089/neu. 2005. 22. 345] [PMID: 15785230].
12. Bao, Y. J.; Li, L. Z.; Li, X. G.; Wang, Y. J. 17Beta-estradiol differentially protects cortical pericontusional zone from programmed cell death after traumatic cerebral contusion at distinct stages via non-genomic and genomic pathways. Mol. Cell. Neurosci., 2011, 48(3), 185-194. [http://dx. doi. org/10. 1016/j. mcn. 2011. 07. 004] [PMID: 21803156].
13. McClean, J.; Nunez, J. L. 17alpha-Estradiol is neuroprotective in male and female rats in a model of early brain injury. Exp. Neurol., 2008, 210(1), 41-50. [http://dx. doi. org/10. 1016/j. expneurol. 2007. 09. 027] [PMID: 17997403].
14. Naderi, V.; Khaksari, M.; Abbasi, R.; Maghool, F. Estrogen provides neuroprotection against brain edema and blood brain barrier disruption through both estrogen receptors α and β following traumatic brain injury. Iran. J. Basic Med. Sci., 2015, 18(2), 138-144. [PMID: 25810887].
15. Schaible, E. V.; Windschugl, J.; Bobkiewicz, W.; Kaburov, Y.; Dangel, L.; Kramer, T.; Huang, C.; Sebastiani, A.; Luh, C.; Werner, C.; Engelhard, K.; Thal, S. C.; Schafer, M. K. 2-Methoxyestradiol confers neuroprotection and inhibits a maladaptive HIF-1α response after traumatic brain injury in mice. J. Neurochem., 2014, 129(6), 940-954. [http://dx. doi. org/10. 1111/jnc. 12708] [PMID: 24606183].
16. Day, N. L.; Floyd, C. L.; D'Alessandro, T. L.; Hubbard, W. J.; Chaudry, I. H. 17β-estradiol confers protection after traumatic brain injury in the rat and involves activation of G protein-coupled estrogen receptor 1. J. Neurotrauma, 2013, 30(17), 1531-1541. [http://dx. doi. org/10. 1089/neu. 2013. 2854] [PMID: 23659385].
17. Kim, H.; Cam-Etoz, B.; Zhai, G.; Hubbard, W. J.; Zinn, K. R.; Chaudry, I. H. Salutary Effects of Estrogen Sulfate for Traumatic Brain Injury. J. Neurotrauma, 2015, 32(16), 1210-1216. [http://dx. doi. org/10. 1089/neu. 2014. 3771] [PMID: 25646701].
18. Wagner, A. K.; McCullough, E. H.; Niyonkuru, C.; Ozawa, H.; Loucks, T. L.; Dobos, J. A.; Brett, C. A.; Santarsieri, M.; Dixon, C. E.; Berga, S. L.; Fabio, A. Acute serum hormone levels: characterization and prognosis after severe traumatic brain injury. J. Neurotrauma, 2011, 28(6), 871-888. [http://dx. doi. org/10. 1089/neu. 2010. 1586] [PMID: 21488721].
19. Groswasser, Z.; Cohen, M.; Keren, O. Female TBI patients recover better than males. Brain Inj., 1998, 12(9), 805-808. [http://dx. doi. org/10. 1080/026990598122197] [PMID: 9755371].
20. Berry, C.; Ley, E. J.; Tillou, A.; Cryer, G.; Margulies, D. R.; Salim, A. The effect of gender on patients with moderate to severe head injuries. J. Trauma, 2009, 67(5), 950-953. [http://dx. doi. org/10. 1097/TA. 0b013e3181ba3354] [PMID: 19901653].
21. Garringer, J. A.; Niyonkuru, C.; McCullough, E. H.; Loucks, T.; Dixon, C. E.; Conley, Y. P.; Berga, S.; Wagner, A. K. Impact of aromatase genetic variation on hormone levels and global outcome after severe TBI. J. Neurotrauma, 2013, 30(16), 1415-1425. [http://dx. doi. org/10. 1089/neu. 2012. 2565] [PMID: 23540392].
22. Hu, R.; Sun, H.; Zhang, Q.; Chen, J.; Wu, N.; Meng, H.; Cui, G.; Hu, S.; Li, F.; Lin, J.; Wan, Q.; Feng, H. G-protein coupled estrogen receptor 1 mediated estrogenic neuroprotection against spinal cord injury. Crit. Care Med., 2012, 40(12), 3230-3237. [http://dx. doi. org/10. 1097/CCM. 0b013e3182657560] [PMID: 22975889].
23. Samantaray, S.; Smith, J. A.; Das, A.; Matzelle, D. D.; Varma, A. K.; Ray, S. K.; Banik, N. L. Low dose estrogen prevents neuronal degeneration and microglial reactivity in an acute model of spinal cord injury: effect of dosing, route of administration, and therapy delay. Neurochem. Res., 2011, 36(10), 1809-1816. [http://dx. doi. org/10. 1007/s11064-011-0498-y] [PMID: 21611834].
24. Das, A.; Smith, J. A.; Gibson, C.; Varma, A. K.; Ray, S. K.; Banik, N. L. Estrogen receptor agonists and estrogen attenuate TNF-α-induced apoptosis in VSC4. 1 motoneurons. J. Endocrinol., 2011, 208(2), 171-182. [http://dx. doi. org/10. 1677/JOE-10-0338] [PMID: 21068071].
25. Singh, M.; Su, C. Progesterone and neuroprotection. Horm. Behav., 2013, 63(2), 284-290. [http://dx. doi. org/10. 1016/j. yhbeh. 2012. 06. 003] [PMID: 22732134].
26. Stein, D. G. A clinical/translational perspective: can a developmental hormone play a role in the treatment of traumatic brain injury? Horm. Behav., 2013, 63(2), 291-300. [http://dx. doi. org/10. 1016/j. yhbeh. 2012. 05. 004] [PMID: 22626570].
27. Roof, R. L.; Duvdevani, R.; Heyburn, J. W.; Stein, D. G. Progesterone rapidly decreases brain edema: treatment delayed up to 24 hours is still effective. Exp. Neurol., 1996, 138(2), 246-251. [http://dx. doi. org/10. 1006/exnr. 1996. 0063] [PMID: 8620923].
28. Roof, R. L.; Duvdevani, R.; Braswell, L.; Stein, D. G. Progesterone facilitates cognitive recovery and reduces secondary neuronal loss caused by cortical contusion injury in male rats. Exp. Neurol., 1994, 129(1), 64-69. [http://dx. doi. org/10. 1006/exnr. 1994. 1147] [PMID: 7925843].
29. Wright, D. W.; Bauer, M. E.; Hoffman, S. W.; Stein, D. G. Serum progesterone levels correlate with decreased cerebral edema after traumatic brain injury in male rats. J. Neurotrauma, 2001, 18(9), 901-909. [http://dx. doi. org/10. 1089/089771501750451820] [PMID: 11565602].
30. Green, P. S.; Yang, S. H.; Simpkins, J. W. Neuroprotective effects of phenolic A ring oestrogens. Novartis Found. Symp., 2000, 230, 202-213. [http://dx. doi. org/10. 1002/0470870818. ch15] [PMID: 10965510].
31. Attella, M. J.; Nattinville, A.; Stein, D. G. Hormonal state affects recovery from frontal cortex lesions in adult female rats. Behav. Neural Biol., 1987, 48(3), 352-367. [http://dx. doi. org/10. 1016/S0163-1047(87)90918-6] [PMID: 3689284].
32. Unterberg, A. W.; Stover, J.; Kress, B.; Kiening, K. L. Edema and brain trauma. Neuroscience, 2004, 129(4), 1021-1029. [http://dx. doi. org/10. 1016/j. neuroscience. 2004. 06. 046] [PMID: 15561417].
33. Allitt, B. J.; Johnstone, V. P.; Richards, K.; Yan, E. B.; Rajan, R. Progesterone Exacerbates Short-Term Effects of Traumatic Brain Injury on Supragranular Responses in Sensory Cortex and Over-Excites Infragranular Responses in the Long Term. J. Neurotrauma, 2016, 33(4), 375-389. [http://dx. doi. org/10. 1089/neu. 2015. 3946] [PMID: 26258958].
34. Lopez-Rodriguez, A. B.; Acaz-Fonseca, E.; Giatti, S.; Caruso, D.; Viveros, M. P.; Melcangi, R. C.; Garcia-Segura, L. M. Correlation of brain levels of progesterone and dehydroepiandrosterone with neurological recovery after traumatic brain injury in female mice. Psychoneuroendocrinology, 2015, 56, 1-11. [http://dx. doi. org/10. 1016/j. psyneuen. 2015. 02. 018] [PMID: 25770855].
35. Peterson, T. C.; Hoane, M. R.; McConomy, K. S.; Farin, F. M.; Bammler, T. K.; MacDonald, J. W.; Kantor, E. D.; Anderson, G. D. A Combination Therapy of Nicotinamide and Progesterone Improves Functional Recovery following Traumatic Brain Injury. J. Neurotrauma, 2015, 32(11), 765-779. [http://dx. doi. org/10. 1089/neu. 2014. 3530] [PMID: 25313690].
36. Zlotnik, A.; Gurevich, B.; Tkachov, S.; Maoz, I.; Shapira, Y.; Teichberg, V. I. Brain neuroprotection by scavenging blood glutamate. Exp. Neurol., 2007, 203(1), 213-220. [http://dx. doi. org/10. 1016/j. expneurol. 2006. 08. 021] [PMID: 17014847].
37. Zlotnik, A.; Gruenbaum, B. F.; Mohar, B.; Kuts, R.; Gruenbaum, S. E.; Ohayon, S.; Boyko, M.; Klin, Y.; Sheiner, E.; Shaked, G.; Shapira, Y.; Teichberg, V. I. The effects of estrogen and progesterone on blood glutamate levels: evidence from changes of blood glutamate levels during the menstrual cycle in women. Biol. Reprod., 2011, 84(3), 581-586. [http://dx. doi. org/10. 1095/biolreprod. 110. 088120] [PMID: 20980684].
38. Tsesis, S.; Gruenbaum, B. F.; Ohayon, S.; Boyko, M.; Gruenbaum, S. E.; Shapira, Y.; Weintraub, A.; Zlotnik, A. The effects of estrogen and progesterone on blood glutamate levels during normal pregnancy in women. Gynecol. Endocrinol., 2013, 29(10), 912-916. [http://dx. doi. org/10. 3109/09513590. 2013. 813467] [PMID: 23862584].
39. Vink, R.; Van Den Heuvel, C. Recent advances in the development of multifactorial therapies for the treatment of traumatic brain injury. Expert Opin. Investig. Drugs, 2004, 13(10), 1263-1274. [http://dx. doi. org/10. 1517/13543784. 13. 10. 1263] [PMID: 15461556].
40. Nudi, E. T.; Jacqmain, J.; Dubbs, K.; Geeck, K.; Salois, G.; Searles, M. A.; Smith, J. S. Combining Enriched Environment, Progesterone, and Embryonic Neural Stem Cell Therapy Improves Recovery after Brain Injury. J. Neurotrauma, 2015, 32(14), 1117-1129. [http://dx. doi. org/10. 1089/neu. 2014. 3618] [PMID: 25268854].
41. Geddes, R. I.; Sribnick, E. A.; Sayeed, I.; Stein, D. G. Progesterone treatment shows benefit in a pediatric model of moderate to severe bilateral brain injury. PLoS One, 2014, 9(1), e87252. [http://dx. doi. org/10. 1371/journal. pone. 0087252] [PMID: 24489882].
42. Si, D.; Li, J.; Liu, J.; Wang, X.; Wei, Z.; Tian, Q.; Wang, H.; Liu, G. Progesterone protects blood-brain barrier function and improves neurological outcome following traumatic brain injury in rats. Exp. Ther. Med., 2014, 8(3), 1010-1014. [PMID: 25120639].
43. Xu, F. F.; Sun, S.; Ho, A. S.; Lee, D.; Kiang, K. M.; Zhang, X. Q.; Wang, A. M.; Wu, E. X.; Lui, W. M.; Liu, B. Y.; Leung, G. K. Effects of progesterone vs. dexamethasone on brain oedema and inflammatory responses following experimental brain resection. Brain Inj., 2014, 28(12), 1594-1601. [http://dx. doi. org/10. 3109/02699052. 2014. 943289] [PMID: 25093611].
44. Pascual, J. L.; Murcy, M. A.; Li, S.; Gong, W.; Eisenstadt, R.; Kumasaka, K.; Sims, C.; Smith, D. H.; Browne, K.; Allen, S.; Baren, J. Neuroprotective effects of progesterone in traumatic brain injury: blunted in vivo neutrophil activation at the blood-brain barrier. Am. J. Surg., 2013, 206(6), 840-845. [http://dx. doi. org/10. 1016/j. amjsurg. 2013. 07. 016] [PMID: 24112683].
45. Stein, D. G. Progesterone exerts neuroprotective effects after brain injury. Brain Res. Brain Res. Rev., 2008, 57(2), 386-397. [http://dx. doi. org/10. 1016/j. brainresrev. 2007. 06. 012] [PMID: 17826842].
46. Wright, D. W.; Kellermann, A. L.; Hertzberg, V. S.; Clark, P. L.; Frankel, M.; Goldstein, F. C.; Salomone, J. P.; Dent, L. L.; Harris, O. A.; Ander, D. S.; Lowery, D. W.; Patel, M. M.; Denson, D. D.; Gordon, A. B.; Wald, M. M.; Gupta, S.; Hoffman, S. W.; Stein, D. G. ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury. Ann. Emerg. Med., 2007, 49(4), 391-402. [http://dx. doi. org/10. 1016/j. annemergmed. 2006. 07. 932].
47. Xiao, G.; Wei, J.; Yan, W.; Wang, W.; Lu, Z. Improved outcomes from the administration of progesterone for patients with acute severe traumatic brain injury: a randomized controlled trial. Crit. Care, 2008, 12(2), R61. [http://dx. doi. org/10. 1186/cc6887] [PMID: 18447940].
48. Aminmansour, B.; Nikbakht, H.; Ghorbani, A.; Rezvani, M.; Rahmani, P.; Torkashvand, M.; Nourian, M.; Moradi, M. Comparison of the administration of progesterone versus progesterone and vitamin D in improvement of outcomes in patients with traumatic brain injury: A randomized clinical trial with placebo group. Adv. Biomed. Res., 2012, 1, 58. [http://dx. doi. org/10. 4103/2277-9175. 100176] [PMID: 23326789].
49. Shakeri, M.; Boustani, M. R.; Pak, N.; Panahi, F.; Salehpour, F.; Lotfinia, I.; Meshkini, A.; Daghighi, S.; vahedi, P.; Khani, M.; Taghiloo, D. Effect of progesterone administration on prognosis of patients with diffuse axonal injury due to severe head trauma. Clin. Neurol. Neurosurg., 2013, 115(10), 2019-2022. [http://dx. doi. org/10. 1016/j. clineuro. 2013. 06. 013] [PMID: 23871679].
50. Santarsieri, M.; Niyonkuru, C.; McCullough, E. H.; Dobos, J. A.; Dixon, C. E.; Berga, S. L.; Wagner, A. K. Cerebrospinal fluid cortisol and progesterone profiles and outcomes prognostication after severe traumatic brain injury. J. Neurotrauma, 2014, 31(8), 699-712. [http://dx. doi. org/10. 1089/neu. 2013. 3177] [PMID: 24354775].
51. Wright, D. W.; Yeatts, S. D.; Silbergleit, R.; Palesch, Y. Y.; Hertzberg, V. S.; Frankel, M.; Goldstein, F. C.; Caveney, A. F.; Howlett-Smith, H.; Bengelink, E. M.; Manley, G. T.; Merck, L. H.; Janis, L. S.; Barsan, W. G.; Investigators, N. Very early administration of progesterone for acute traumatic brain injury. N. Engl. J. Med., 2014, 371(26), 2457-2466. [http://dx. doi. org/10. 1056/NEJMoa1404304] [PMID: 25493974].
52. Skolnick, B. E.; Maas, A. I.; Narayan, R. K.; van der Hoop, R. G.; MacAllister, T.; Ward, J. D.; Nelson, N. R.; Stocchetti, N.; Investigators, S. T. A clinical trial of progesterone for severe traumatic brain injury. N. Engl. J. Med., 2014, 371(26), 2467-2476. [http://dx. doi. org/10. 1056/NEJMoa1411090] [PMID: 25493978].
53. Lin, C.; He, H.; Li, Z.; Liu, Y.; Chao, H.; Ji, J.; Liu, N. Efficacy of progesterone for moderate to severe traumatic brain injury: a metaanalysis of randomized clinical trials. Sci. Rep., 2015, 5, 13442. [http://dx. doi. org/10. 1038/srep13442] [PMID: 26304556].
54. Zeng, Y.; Zhang, Y.; Ma, J.; Xu, J. Progesterone for Acute Traumatic Brain Injury: A Systematic Review of Randomized Controlled Trials. PLoS One, 2015, 10(10), e0140624. [http://dx. doi. org/10. 1371/journal. pone. 0140624] [PMID: 26473361].
55. Vink, R.; Nimmo, A. J. Multifunctional drugs for head injury. Neurotherapeutics, 2009, 6(1), 28-42. [http://dx. doi. org/10. 1016/j. nurt. 2008. 10. 036] [PMID: 19110197].
56. Thomas, A. J.; Nockels, R. P.; Pan, H. Q.; Shaffrey, C. I.; Chopp, M. Progesterone is neuroprotective after acute experimental spinal cord trauma in rats. Spine, 1999, 24(20), 2134-2138. [http://dx. doi. org/10. 1097/00007632-199910150-00013] [PMID: 10543012].
57. De Nicola, A. F.; Labombarda, F.; Gonzalez, D. M. C.; Gonzalez, S. L.; Garay, L.; Meyer, M.; Gargiulo, G.; Guennoun, R.; Schumacher, M. Progesterone neuroprotection in traumatic CNS injury and motoneuron degeneration. Front. Neuroendocrinol., 2009, 30(2), 173-187. [http://dx. doi. org/10. 1016/j. yfrne. 2009. 03. 001] [PMID: 19318112].
58. Guennoun, R.; Meffre, D.; Labombarda, F.; Gonzalez, S. L.; Gonzalez Deniselle, M. C.; Stein, D. G.; De Nicola, A. F.; Schumacher, M. The membrane-associated progesterone-binding protein 25-Dx: expression, cellular localization and up-regulation after brain and spinal cord injuries. Brain Res. Brain Res. Rev., 2008, 57(2), 493-505. [http://dx. doi. org/10. 1016/j. brainresrev. 2007. 05. 009] [PMID: 17618691].
59. Behl, C.; Manthey, D. Neuroprotective activities of estrogen: an update. J. Neurocytol., 2000, 29(5-6), 351-358. [http://dx. doi. org/10. 1023/A: 1007109222673] [PMID: 11424951].
60. Dluzen, D. E. Unconventional effects of estrogen uncovered. Trends Pharmacol. Sci., 2005, 26(10), 485-487. [http://dx. doi. org/10. 1016/j. tips. 2005. 08. 001] [PMID: 16122814].
61. Griffin, G. D.; Flanagan-Cato, L. M. Ovarian hormone action in the hypothalamic ventromedial nucleus: remodelling to regulate reproduction. J. Neuroendocrinol., 2011, 23(6), 465-471. [http://dx. doi. org/10. 1111/j. 1365-2826. 2011. 02143. x] [PMID: 21518031].
62. Simpkins, J. W.; Singh, M.; Brock, C.; Etgen, A. M. Neuroprotection and estrogen receptors. Neuroendocrinology, 2012, 96(2), 119-130. [http://dx. doi. org/10. 1159/000338409] [PMID: 22538356].
63. Woolley, C. S.; McEwen, B. S. Roles of estradiol and progesterone in regulation of hippocampal dendritic spine density during the estrous cycle in the rat. J. Comp. Neurol., 1993, 336(2), 293-306. [http://dx. doi. org/10. 1002/cne. 903360210] [PMID: 8245220].
64. Dubal, D. B.; Shughrue, P. J.; Wilson, M. E.; Merchenthaler, I.; Wise, P. M. Estradiol modulates bcl-2 in cerebral ischemia: a potential role for estrogen receptors. J. Neurosci., 1999, 19(15), 6385-6393. [PMID: 10414967].
65. Zhang, Q. G.; Wang, R.; Khan, M.; Mahesh, V.; Brann, D. W. Role of Dickkopf-1, an antagonist of the Wnt/beta-catenin signaling pathway, in estrogen-induced neuroprotection and attenuation of tau phosphorylation. J. Neurosci., 2008, 28(34), 8430-8441. [http://dx. doi. org/10. 1523/JNEUROSCI. 2752-08. 2008] [PMID: 18716201].
66. Yang, L. C.; Zhang, Q. G.; Zhou, C. F.; Yang, F.; Zhang, Y. D.; Wang, R. M.; Brann, D. W. Extranuclear estrogen receptors mediate the neuroprotective effects of estrogen in the rat hippocampus. PLoS One, 2010, 5(5), e9851. [http://dx. doi. org/10. 1371/journal. pone. 0009851] [PMID: 20479872].
67. Li, L. Z.; Bao, Y. J.; Zhao, M. 17beta-estradiol attenuates programmed cell death in cortical pericontusional zone following traumatic brain injury via upregulation of ERalpha and inhibition of caspase-3 activation. Neurochem. Int., 2011, 58(1), 126-133. [http://dx. doi. org/10. 1016/j. neuint. 2010. 11. 006] [PMID: 21093516].
68. Moosmann, B.; Behl, C. The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties. Proc. Natl. Acad. Sci. USA, 1999, 96(16), 8867-8872. [http://dx. doi. org/10. 1073/pnas. 96. 16. 8867] [PMID: 10430862].
69. Brann, D. W.; Dhandapani, K.; Wakade, C.; Mahesh, V. B.; Khan, M. M. Neurotrophic and neuroprotective actions of estrogen: basic mechanisms and clinical implications. Steroids, 2007, 72(5), 381-405. [http://dx. doi. org/10. 1016/j. steroids. 2007. 02. 003] [PMID: 17379265].
70. Arevalo, M. A.; Santos-Galindo, M.; Bellini, M. J.; Azcoitia, I.; Garcia-Segura, L. M. Actions of estrogens on glial cells: Implications for neuroprotection. Biochim. Biophys. Acta, 2010, 1800(10), 1106-1112. [http://dx. doi. org/10. 1016/j. bbagen. 2009. 10. 002] [PMID: 19818384].
71. Bruce-Keller, A. J.; Keeling, J. L.; Keller, J. N.; Huang, F. F.; Camondola, S.; Mattson, M. P. Antiinflammatory effects of estrogen on microglial activation. Endocrinology, 2000, 141(10), 3646-3656. [PMID: 11014219].
72. Rusa, R.; Alkayed, N. J.; Crain, B. J.; Traystman, R. J.; Kimes, A. S.; London, E. D.; Klaus, J. A.; Hurn, P. D. 17beta-estradiol reduces stroke injury in estrogen-deficient female animals. Stroke, 1999, 30(8), 1665-1670. [http://dx. doi. org/10. 1161/01. STR. 30. 8. 1665] [PMID: 10436119].
73. Teichberg, V. I.; Cohen-Kashi-Malina, K.; Cooper, I.; Zlotnik, A. Homeostasis of glutamate in brain fluids: an accelerated brain-toblood efflux of excess glutamate is produced by blood glutamate scavenging and offers protection from neuropathologies. Neuroscience, 2009, 158(1), 301-308. [http://dx. doi. org/10. 1016/j. neuroscience. 2008. 02. 075] [PMID: 18423998].
74. Castillo, J.; Davalos, A.; Naveiro, J.; Noya, M. Neuroexcitatory amino acids and their relation to infarct size and neurological deficit in ischemic stroke. Stroke, 1996, 27(6), 1060-1065. [http://dx. doi. org/10. 1161/01. STR. 27. 6. 1060] [PMID: 8650715].
75. Zauner, A.; Bullock, R.; Kuta, A. J.; Woodward, J.; Young, H. F. Glutamate release and cerebral blood flow after severe human head injury. Acta Neurochir. Suppl. (Wien), 1996, 67, 40-44. [PMID: 8870800].
76. Castillo, J.; Davalos, A.; Alvarez-Sabin, J.; Pumar, J. M.; Leira, R.; Silva, Y.; Montaner, J.; Kase, C. S. Molecular signatures of brain injury after intracerebral hemorrhage. Neurology, 2002, 58(4), 624-629. [http://dx. doi. org/10. 1212/WNL. 58. 4. 624] [PMID: 11865143].
77. Johnston, M. V.; Trescher, W. H.; Ishida, A.; Nakajima, W. Neurobiology of hypoxic-ischemic injury in the developing brain. Pediatr. Res., 2001, 49(6), 735-741. [http://dx. doi. org/10. 1203/00006450-200106000-00003] [PMID: 11385130].
78. Andreadou, E.; Kapaki, E.; Kokotis, P.; Paraskevas, G. P.; Katsaros, N.; Libitaki, G.; Petropoulou, O.; Zis, V.; Sfagos, C.; Vassilopoulos, D. Plasma glutamate and glycine levels in patients with amyotrophic lateral sclerosis. In Vivo, 2008, 22(1), 137-141. [PMID: 18396796].
79. Bunting, H.; Still, R.; Williams, D. R.; Gravenor, M.; Austin, M. W. Evaluation of plasma glutamate levels in normal tension glaucoma. Ophthalmic Res., 2010, 43(4), 197-200. [http://dx. doi. org/10. 1159/000272024] [PMID: 20068372].
80. Espey, M. G.; Basile, A. S.; Heaton, R. K.; Ellis, R. J. Increased glutamate in CSF and plasma of patients with HIV dementia. Neurology, 2002, 58(9), 1439. [http://dx. doi. org/10. 1212/WNL. 58. 9. 1439] [PMID: 12011305].
81. Takano, T.; Lin, J. H.; Arcuino, G.; Gao, Q.; Yang, J.; Nedergaard, M. Glutamate release promotes growth of malignant gliomas. Nat. Med., 2001, 7(9), 1010-1015. [http://dx. doi. org/10. 1038/nm0901-1010] [PMID: 11533703].
82. Zlotnik, A.; Ohayon, S.; Gruenbaum, B. F.; Gruenbaum, S. E.; Mohar, B.; Boyko, M.; Klin, Y.; Sheiner, E.; Shaked, G.; Shapira, Y.; Teichberg, V. I. Determination of factors affecting glutamate concentrations in the whole blood of healthy human volunteers. J. Neurosurg. Anesthesiol., 2011, 23(1), 45-49. [http://dx. doi. org/10. 1097/ANA. 0b013e3181f82a8f] [PMID: 21248494].
83. Stover, J. F.; Kempski, O. S. Anesthesia increases circulating glutamate in neurosurgical patients. Acta Neurochir. (Wien), 2005, 147(8), 847-853. [http://dx. doi. org/10. 1007/s00701-005-0562-y] [PMID: 15968470].
84. Fernholm, R.; Thoren, M.; Hoybye, C.; Anderstam, B.; Pernow, Y.; Saaf, M.; Hall, K. Amino acid profiles in adults with growth hormone (GH) deficiency before and during GH replacement therapy. Growth Horm. IGF Res., 2009, 19(3), 206-211. [http://dx. doi. org/10. 1016/j. ghir. 2008. 09. 001] [PMID: 18990596].
85. Abraham, G. E.; Odell, W. D.; Swerdloff, R. S.; Hopper, K. Simultaneous radioimmunoassay of plasma FSH, LH, progesterone, 17-hydroxyprogesterone, and estradiol-17 beta during the menstrual cycle. J. Clin. Endocrinol. Metab., 1972, 34(2), 312-318. [http://dx. doi. org/10. 1210/jcem-34-2-312] [PMID: 5059762].
86. Barile, G.; Sica, G.; Montemurro, A.; Iacobelli, S.; Corradini, M. Levels of estrogen and progesterone receptor in human endometrium during the menstrual cycle. Eur. J. Obstet. Gynecol. Reprod. Biol., 1979, 9(4), 243-246. [http://dx. doi. org/10. 1016/0028-2243(79)90062-5] [PMID: 264091].
87. Goebelsmann, U.; Midgley, A. R., Jr; Jaffe, R. B. Regulation of human gonadotropins: VII. Daily individual urinary estrogens, pregnanediol and serum luteinizing and follicle stimulating hormones during the menstrual cycle. J. Clin. Endocrinol. Metab., 1969, 29(9), 1222-1230. [http://dx. doi. org/10. 1210/jcem-29-9-1222] [PMID: 5808527].
88. Roger, M.; Veinante, A.; Soldat, M. C.; Tardy, J.; Tribondeau, E.; Scholler, R. Simultaneous study of plasma gonadotropins, estrogens, progesterone and 17-hydroxyprogesterone during the ovulatory cycle. Nouv. Presse Med., 1975, 4(30), 2173-2178. [Simultaneous study of plasma gonadotropins, estrogens, progesterone and 17-hydroxyprogesterone during the ovulatory cycle]. [PMID: 1178478].
89. Sherman, B. M.; Korenman, S. G. Hormonal characteristics of the human menstrual cycle throughout reproductive life. J. Clin. Invest., 1975, 55(4), 699-706. [http://dx. doi. org/10. 1172/JCI107979] [PMID: 1120778].
90. Sherman, B. M.; West, J. H.; Korenman, S. G. The menopausal transition: analysis of LH, FSH, estradiol, and progesterone concentrations during menstrual cycles of older women. J. Clin. Endocrinol. Metab., 1976, 42(4), 629-636. [http://dx. doi. org/10. 1210/jcem-42-4-629] [PMID: 1262439].
91. Cimarosti, H.; O'Shea, R. D.; Jones, N. M.; Horn, A. P.; Simao, F.; Zamin, L. L.; Nassif, M.; Frozza, R.; Netto, C. A.; Beart, P. M.; Salbego, C. The effects of estradiol on estrogen receptor and glutamate transporter expression in organotypic hippocampal cultures exposed to oxygen-glucose deprivation. Neurochem. Res., 2006, 31(4), 483-490. [http://dx. doi. org/10. 1007/s11064-006-9043-9] [PMID: 16758356].
92. Green, P. S.; Simpkins, J. W. Neuroprotective effects of estrogens: potential mechanisms of action. Int. J. Dev. Neurosci., 2000, 18(4-5), 347-358. [http://dx. doi. org/10. 1016/S0736-5748(00)00017-4] [PMID: 10817919].
93. Chen, J.; Lei, T.; Ritz, M. F.; Mendelowitsch, A. Effect of 17 betaestradiol on the brain damage and metabolic changes in rats. J. Tongji Med. Univ., 2001, 21(1), 62-64, 74. [http://dx. doi. org/10. 1007/BF02888040] [PMID: 11523252].
94. Stein, D. G.; Wright, D. W.; Kellermann, A. L. Does progesterone have neuroprotective properties? Ann. Emerg. Med., 2008, 51(2), 164-172. [http://dx. doi. org/10. 1016/j. annemergmed. 2007. 05. 001] [PMID: 17588708].
95. Singh, M. Progesterone-induced neuroprotection. Endocrine, 2006, 29(2), 271-274. [http://dx. doi. org/10. 1385/ENDO: 29: 2: 271] [PMID: 16785602].
96. Djebaili, M.; Guo, Q.; Pettus, E. H.; Hoffman, S. W.; Stein, D. G. The neurosteroids progesterone and allopregnanolone reduce cell death, gliosis, and functional deficits after traumatic brain injury in rats. J. Neurotrauma, 2005, 22(1), 106-118. [http://dx. doi. org/10. 1089/neu. 2005. 22. 106] [PMID: 15665606].
97. Guo, Q.; Sayeed, I.; Baronne, L. M.; Hoffman, S. W.; Guennoun, R.; Stein, D. G. Progesterone administration modulates AQP4 expression and edema after traumatic brain injury in male rats. Exp. Neurol., 2006, 198(2), 469-478. [http://dx. doi. org/10. 1016/j. expneurol. 2005. 12. 013] [PMID: 16445913].
98. Pettus, E. H.; Wright, D. W.; Stein, D. G.; Hoffman, S. W. Progesterone treatment inhibits the inflammatory agents that accompany traumatic brain injury. Brain Res., 2005, 1049(1), 112-119. [http://dx. doi. org/10. 1016/j. brainres. 2005. 05. 004] [PMID: 15932748].
99. Punnonen, R.; Nummi, S.; Ylikorkala, O.; Alapiessa, U.; Karvonen, P.; Vinikka, L. A composite picture of the normal menstrual cycle. Acta Obstet. Gynecol. Scand. Suppl., 1976, 51, 63-70. [PMID: 1065183].
100. Szydlowska, K.; Tymianski, M. Calcium, ischemia and excitotoxicity. Cell Calcium, 2010, 47(2), 122-129. [http://dx. doi. org/10. 1016/j. ceca. 2010. 01. 003] [PMID: 20167368].
101. Luoma, J. I.; Kelley, B. G.; Mermelstein, P. G. Progesterone inhibition of voltage-gated calcium channels is a potential neuroprotective mechanism against excitotoxicity. Steroids, 2011, 76(9), 845-855. [PMID: 21371490].